KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating
That same day, Evercore ISI analyst Elizabeth Anderson lowered the price target to $50 from $65 while keeping an Outperform rating.
Hinge Health Inc. (HNGE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | BIT Capital GmbH Jan Beckers | 3,316,101 | $154,032,891 | +80% | 5.67% |
| 2. | Tiger Global Management LLC Chase Coleman And Feroz Dewan | 1,805,751 | $83,877,134 | +228% | 0.28% |
| 3. | Millennium Management Israel Englander | 1,479,642 | $68,729,371 | +193% | 0.03% |
| 4. | Braidwell LP Alex Karnal | 1,304,623 | $60,599,738 | +44% | 1.94% |
| 5. | Alyeska Investment Group Anand Parekh | 1,226,972 | $56,992,849 | -6% | 0.16% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | $0.00 | 0 | 2026-02-18 | Filing | |
| $0.00 | 0 | $0.00 | 0 | 2026-02-17 | Filing | |
| $0.00 | 0 | $0.00 | 0 | 2026-02-13 | Filing | |
| $0.00 | 0 | $0.00 | 0 | 2026-02-12 | Filing | |
| $40.26 | 166,665 | $6,710,516.23 | 0 | 2026-02-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,375,164 | $435,476,368 | 32.56% | |
| 2. | 3,704,524 | $172,075,140 | 100% | |
| 3. | 2,605,532 | $121,026,961 | 0% | |
| 4. | 1,566,811 | $72,778,371 | 0.01% | |
| 5. | 1,273,510 | $59,154,540 | 1.3% |
News See All
Stifel Views Downtime as Attractive Entry Opportunity for Hinge Health, Inc. (HNGE) Shares
TheFly reported on February 5 that Stifel lowered its price target on HNGE to $59 from $66 and maintained a Buy rating on the shares.
15 Innovative Healthcare Stocks to Buy According to Analysts
Over the last two years, artificial intelligence has propelled global financial markets into a boom, with stocks reaching all-time highs.
Hinge Health (HNGE) Climbs 17% on Revenue Jump, Double-Digit Growth Hopes
Hinge Health extended its winning streak to a third consecutive day on Wednesday, surging 17.28 percent to close at $38.76 apiece as investors took heart from strong revenue performance last year, bolstering...
Hinge Health, Inc. (NYSE:HNGE) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for joining us, welcome to the Hinge Health Fourth Quarter 2025 Earnings Call. After today's prepared remarks, we will host a question and answer session.
Jim Cramer Shed Light on These 19 Stocks Recently
Let's talk about the biggest deal of the week, and that's the nomination of Kevin Warsh as the next chief of the Fed. Warsh is a banker. He's a financier. He's a real smart guy. He's rigorous.
Here is What Analysts Have to Say About Hinge Health (HNGE)
On December 19, the consensus ratings indicate a strong bullish stance towards Hinge Health (NYSE:HNGE).
15 Most Promising Mid-Cap Healthcare Stocks Under $50
Traditionally, healthcare stocks have been considered defensive, offering strong immunity to business cycles.
Hinge Health (HNGE) Soars 8% on Upbeat Outlook
Hinge Health snapped a five-day losing streak on Wednesday, adding 8.57 percent to close at $44.10 apiece as investors cheered its higher growth outlook for full-year 2025 despite a mixed earnings performance...
Hedge Fund Resource Center